These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30028534)

  • 1. Diagnosis of erectile dysfunction can be used to improve screening for Type 2 diabetes mellitus.
    Carrillo-Larco RM; Luza-Dueñas AC; Urdániga-Hung M; Bernabé-Ortiz A
    Diabet Med; 2018 Nov; 35(11):1538-1543. PubMed ID: 30028534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.
    Bernabe-Ortiz A; Perel P; Miranda JJ; Smeeth L
    Prim Care Diabetes; 2018 Dec; 12(6):517-525. PubMed ID: 30131300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
    Barengo NC; Tamayo DC; Tono T; Tuomilehto J
    Prim Care Diabetes; 2017 Feb; 11(1):86-93. PubMed ID: 27727004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and northwestern zone of Tigray, northern Ethiopia: a cross-sectional study.
    Seid A; Gerensea H; Tarko S; Zenebe Y; Mezemir R
    BMC Endocr Disord; 2017 Mar; 17(1):16. PubMed ID: 28298205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neck Circumference and its Correlation to Other Anthropometric Parameters and Finnish Diabetes Risk Score (FINDRISC).
    Volaco A; Martins CM; Soares JQ; Cavalcanti AM; Moyses ST; Filho RP; Baena CP; Precoma DB
    Curr Diabetes Rev; 2018; 14(5):464-471. PubMed ID: 28969558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of three diabetes prediction scores in a Spanish cohort: does adding high risk for depression improve the validation of the FINDRISC score (FINDRISC-MOOD)?
    Salinero-Fort M; Mostaza-Prieto JM; Lahoz-Rallo C; Cárdenas-Valladolid J; Iriarte-Campo V; Estirado-Decabo E; Garcia-Iglesias F; Gonzalez-Alegre T; Fernandez-Puntero B; Cornejo-Del Rio VM; Sanchez-Arroyo V; Sabín-Rodríguez C; López-López S; Gómez-Campelo P; Taulero-Escalera B; Rodriguez-Artalejo F; San Andrés-Rebollo FJ; De Burgos-Lunar C;
    BMJ Open; 2024 Jun; 14(6):e083121. PubMed ID: 38844393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies.
    Kouidrat Y; Pizzol D; Cosco T; Thompson T; Carnaghi M; Bertoldo A; Solmi M; Stubbs B; Veronese N
    Diabet Med; 2017 Sep; 34(9):1185-1192. PubMed ID: 28722225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile dysfunction and associated factors among men with diabetes mellitus from a tertiary diabetic center in Northern Sri Lanka.
    Nisahan B; Kumanan T; Rajeshkannan N; Peranantharajah T; Aravinthan M
    BMC Res Notes; 2019 Apr; 12(1):210. PubMed ID: 30953562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erectile dysfunction cannot be used in primary screening of pre-diabetes.
    Ettala OO; Korhonen PE; Syvänen KT; Kaipia AJ; Vahlberg TJ; Aarnio PT; Boström PJ
    Diabetes Res Clin Pract; 2015 Jun; 108(3):e60-2. PubMed ID: 25779867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between blood glucose levels and autonomic symptoms in Peru.
    Angeles-Zurita G; Narro-Fuentes M; Bernabe-Ortiz A
    Prim Care Diabetes; 2022 Oct; 16(5):709-713. PubMed ID: 36041979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A community-based study on prevalence and correlates of erectile dysfunction among Kinondoni District Residents, Dar Es Salaam, Tanzania.
    Pallangyo P; Nicholaus P; Kisenge P; Mayala H; Swai N; Janabi M
    Reprod Health; 2016 Nov; 13(1):140. PubMed ID: 27899129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.
    Grover SA; Lowensteyn I; Kaouache M; Marchand S; Coupal L; DeCarolis E; Zoccoli J; Defoy I
    Arch Intern Med; 2006 Jan; 166(2):213-9. PubMed ID: 16432091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.
    Wang J; Stancáková A; Kuusisto J; Laakso M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3858-62. PubMed ID: 20463095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol consumption and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: Baseline data from the Dogo Study.
    Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Ueda T; Tanaka K; Senba H; Todo Y; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
    Alcohol; 2016 Sep; 55():17-22. PubMed ID: 27788774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for erectile dysfunction and associated cardiovascular risk factors in Israeli men.
    Heruti RJ; Steinvil A; Shochat T; Saar N; Mashav N; Arbel Y; Justo D
    Isr Med Assoc J; 2008 Oct; 10(10):686-90. PubMed ID: 19009946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Predictors of Erectile Dysfunction in Bangladeshi Men with Type 2 Diabetes Mellitus: Experience from a Tertiary Center.
    Mahbub MI; Kamrul-Hasan AB; Selim S; Mir AS; Saifuddin M; Pathan MF
    Mymensingh Med J; 2019 Jan; 28(1):137-143. PubMed ID: 30755562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age.
    Cleveringa FG; Meulenberg MG; Gorter KJ; van den Donk M; Rutten GE
    J Diabetes Complications; 2009; 23(3):153-9. PubMed ID: 18413203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.